Health-related Quality of Life in Liver Cirrhosis Patients Using SF-36 and CLDQ Questionnaires
Overview
Authors
Affiliations
Aim Of The Study: To determine the factors that are likely to influence the domains of health-related quality of life (HRQOL) using SF-36 and CLDQ questionnaires in patients with liver cirrhosis.
Material And Methods: Patients with liver cirrhosis were compared with age- and gender-matched healthy controls for physical and mental components of the SF-36 score. Effects of age, co-morbidity, namely diabetes, severity of liver disease and complications of liver cirrhosis on HRQOL using self-administered or by direct interview SF-36 and CLDQ questionnaires were studied. Statistical analysis: chi square test, ANOVA, Kruskal-Wallis test and stepwise linear regression analysis. A value of < 0.05 was considered significant.
Results: Regarding SF-36 score, except for bodily pain, 149 patients had significantly low individual and composite domain scores ( value < 0.0001) compared to age/gender-matched controls. Patients below 45 years, the majority of whom belonged to Child-Turcotte-Pugh (CTP) class C with a high Model of End-Stage Liver Disease (MELD) and higher rates of complication had low SF-36 for bodily pain (KW < 0.005) and those above 55 years for physical function ( < 0.05). Both the physical components had a major impact on mental composite score (MCS) (KW < 0.05). The overall CLDQ score was also low in patients below 45 years old ( < 0.05). Diabetes with or without other co-morbid conditions had no effect on SF-36 or CLDQ scores, while non-diabetic co-morbid conditions did on physical domains (physical function, bodily pain and role physical) and the physical component score of SF-36 (KW < 0.01 to < 0.0001). In linear regression, MELD had a direct and significant association with overall PCS, MCS and CLDQ.
Conclusions: Age below 45 years, higher MELD and CTP score with the presence of ascites and hepatic encephalopathy affect the overall CLDQ scores.
Shapuram S, Gunnala N, Artham H, Venishetty S, Kolli S, Kolar S Hepatol Commun. 2024; 8(10).
PMID: 39330961 PMC: 11441862. DOI: 10.1097/HC9.0000000000000529.
Etiological Spectrum of Cirrhosis in India: A Systematic Review and Meta-analysis.
Swaroop S, Vaishnav M, Arora U, Biswas S, Aggarwal A, Sarkar S J Clin Exp Hepatol. 2024; 14(2):101291.
PMID: 38544766 PMC: 10964076. DOI: 10.1016/j.jceh.2023.10.002.
Gazder D, Parvez S, Gazder N, Muqtadir J Cureus. 2024; 16(2):e53766.
PMID: 38465018 PMC: 10922217. DOI: 10.7759/cureus.53766.
Integrating smart phone applications in the management of cirrhotic patients: A scoping review.
Hasan M, Bidargaddi N, Muller K, Ramachandran J, Narayana S, Wigg A JGH Open. 2024; 7(12):826-831.
PMID: 38162857 PMC: 10757474. DOI: 10.1002/jgh3.13021.
Rajpurohit S, Musunuri B, Mohan P, Bhat G, Shetty S J Clin Exp Hepatol. 2023; 14(1):101264.
PMID: 38076365 PMC: 10709188. DOI: 10.1016/j.jceh.2023.07.417.